|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/545 | (2006.01) |
| A61P 19/02 | (2006.01) | ||
| A61K 38/20 | (2006.01) |
| (11) | Number of the document | 3470421 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18191564.6 |
| Date of filing the European patent application | 2011-07-29 | |
| (97) | Date of publication of the European application | 2019-04-17 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 36879910 P | 2010-07-29 | US | |
| 201161436178 P | 2011-01-25 | US | |
| 201161436184 P | 2011-01-25 | US | |
| 201161493966 P | 2011-06-06 | US | |
| 201161493967 P | 2011-06-06 | US |
| (72) |
BARNES, Thomas M. , US
HOU, Jinzhao , US
KING, Bracken M. , US
|
| (73) |
Buzzard Pharmaceuticals AB ,
Skeppsbron 16, 111 30 Stockholm,
SE
|
| (54) | CHIMERIC IL-1 RECEPTOR TYPE I ANTAGONISTS |
| CHIMERIC IL-1 RECEPTOR TYPE I ANTAGONISTS |